Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clearing for insight: A light-sheet microscopy workflow for 3D vascular reconstruction in human first trimester placental villi and decidua.

Placenta·2026
Same author

The journey of maternal platelets through the utero-placental circulation: routes, interactions, and physiological implications.

Molecular human reproduction·2026
Same author

Associations between physical activity, sedentary behavior, body mass index and changes in placental structure and vascularization - data from the FitMum randomized controlled trial.

Placenta·2026
Same author

Exploring fetal cells in maternal blood in relation to rupture of the fetal membranes.

Placenta·2026
Same author

A comprehensive European Colorectal Cancer Cohort dataset.

Scientific data·2026
Same author

Preeclampsia 2.0: limitations and challenges of the two-stage hypothesis, and beyond.

Molecular human reproduction·2026

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K

Maternal-fetal interactions, predictive markers for preeclampsia, and programming.

Berthold Huppertz1

  • 1Institute of Cell Biology, Histology and Embryology, Medical University of Graz, Austria.

Journal of Reproductive Immunology
|December 24, 2014
PubMed
Summary

Identifying predictive biomarkers in maternal blood during pregnancy is challenging due to complex maternal-placental crosstalk. Understanding marker origins and preeclampsia

Keywords:
BiomarkerPredictionPreeclampsiaPregnancyProgramming

More Related Videos

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
14:40

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings

Published on: October 25, 2015

10.0K
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

11.4K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K
Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
14:40

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings

Published on: October 25, 2015

10.0K
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

11.4K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Biomarker Discovery

Background:

  • Pregnancy involves intricate interactions between maternal and fetal systems through the placenta, creating significant crosstalk.
  • This crosstalk complicates the identification of predictive biomarkers in maternal blood, as their origin (maternal, placental, or both) can be ambiguous.
  • Variations in marker concentrations, influenced by numerous factors, have historically misled research efforts to pinpoint their sources and the roles of the placenta and maternal vasculature.

Purpose of the Study:

  • To address the challenges in identifying reliable predictive biomarkers in maternal blood during pregnancy.
  • To elucidate the complexities arising from maternal-placental crosstalk and its impact on biomarker interpretation.
  • To explore the reasons behind the variable predictive value of biomarkers and the diverse etiological pathways of preeclampsia.

Main Methods:

  • Review and analysis of existing literature on maternal-fetal crosstalk and biomarker development.
  • Examination of specific examples of predictive biomarkers, such as placental protein 13 (PP13) and placental growth factor (PlGF).
  • Discussion of the implications of diverse preeclampsia development routes on biomarker efficacy and long-term health outcomes.

Main Results:

  • Maternal blood biomarker analysis is hindered by the complex interplay between maternal and placental systems.
  • Markers like PP13 and PlGF, originating from both mother and placenta, illustrate the difficulty in source attribution and concentration variability.
  • The multifaceted origins of preeclampsia contribute to the inconsistent predictive power of biomarkers and varying long-term effects.

Conclusions:

  • Accurate identification of predictive biomarkers for pregnancy complications requires careful consideration of maternal-placental crosstalk.
  • The diverse etiologies of preeclampsia underscore the need for nuanced approaches to biomarker validation and clinical application.
  • Understanding these complexities is crucial for improving prediction, management, and understanding of long-term health consequences.